Helicobacter pylori-Associated Diseases.

被引:64
作者
Sanders M.K. [1 ]
Peura D.A. [1 ]
机构
[1] Division of Gastroenterology and Hepatology, University of Virginia Health Systems, PO Box 800708, Charlottesville, 22908-0708, VA
关键词
Gastric Cancer; Pylorus Infection; Peptic Ulcer Disease; CagA; Eradication Therapy;
D O I
10.1007/s11894-002-0019-x
中图分类号
学科分类号
摘要
Since the initial report 20 years ago by Marshall and Warren of an unidentified curved bacillus located on the gastric epithelium of patients with chronic active gastritis, the discovery of Helicobacter pylori and its association with a number of gastrointestinal diseases has revolutionized the field of gastroenterology. Although the association of H. pylori infection with peptic ulcer disease, chronic gastritis, mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma has been well documented over the past two decades, other areas remain less clear, including the role of H. pylori in gastropathy associated with nonsteroidal anti-inflammatory drugs, gastroesophageal reflux disease, and both uninvestigated and nonulcer dyspepsia. Although these areas still remain somewhat controversial, recent reports further clarify the role of H. pylori in these conditions. A review of the recent literature regarding H. pylori-associated diseases is presented along with recommendations for diagnosis and treatment of H. pylori infection.
引用
收藏
页码:448 / 454
页数:6
相关论文
共 124 条
[1]  
Go MF(2002)Review article: natural history and epidemiology of Helicobacter pylori infection Aliment Pharmacol Ther 16 3-15
[2]  
Hawkey CJ(1998)Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 352 1016-1021
[3]  
Tulassay Z(1997)Randomised trial of eradication of Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers Lancet 350 975-979
[4]  
Szczepanski L(2002); Lancet 359 14-22
[5]  
Chan FK(2002)Eradication of Helicobacter pylori and risk of peptic ulcer in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomized trial Lancet 359 9-13
[6]  
Sung JJ(2002)Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 16 167-180
[7]  
Chung SC(2001)Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 967-973
[8]  
Huang JQ(2002)Helicobacter pylori infection in peptic ulcer hemorrhage [review] Aliment Pharmacol Ther 16 66-78
[9]  
Sridhar S(2000)The problem of Helicobacter pylori-negative idiopathic ulcer disease Baillieres Best Pract Res Clin Gastroenterol 14 109-117
[10]  
Hunt RH(2001)The role of proton pump inhibitors in non-H. pylori-related ulcers [review] Aliment Pharmacol Ther 15 2-5